Herb–drug interactions between androgenic Chinese herbal medicines and androgen receptor antagonist on tumor growth: Studies on two xenograft prostate cancer animal models
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Herb–drug
interactions between androgenic Chinese herbal medicines and androgen receptor antagonist on tumor growth: Studies on two xenograft prostate cancer animal models
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-01-16
DOI
10.1002/ptr.7020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology : Reproducibility of natural product research
- (2020) Angelo A. Izzo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models
- (2020) Zhen-Biao Zhang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Best practice in research – Overcoming common challenges in phytopharmacological research
- (2019) Michael Heinrich et al. JOURNAL OF ETHNOPHARMACOLOGY
- Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway
- (2018) Ruijuan Zhou et al. BMC Complementary and Alternative Medicine
- Combinatorial Effect of Abiraterone Acetate and NVP-BEZ235 on Prostate Tumor Progression in Rats
- (2018) Bianca Facchim Gonçalves et al. Hormones & Cancer
- Systems pharmacology exploration of botanic drug pairs reveals the mechanism for treating different diseases
- (2016) Wei Zhou et al. Scientific Reports
- Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch
- (2013) J B Tennakoon et al. ONCOGENE
- FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants
- (2013) Laura R. Bohrer et al. PROSTATE
- Complementary and Alternative Medicines in Prostate Cancer: From Bench to Bedside?
- (2012) S. J. Klempner et al. ONCOLOGIST
- Impact of the Herbal Medicine Sophora flavescens on the Oral Pharmacokinetics of Indinavir in Rats: The Involvement of CYP3A and P-Glycoprotein
- (2012) Jia-Ming Yang et al. PLoS One
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells
- (2010) Hideki Koizumi et al. FEBS LETTERS
- Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors
- (2009) Johanna Tuomela et al. BMC CANCER
- Clinically based evidence of drug–herb interactions: a systematic review
- (2009) Deborah A Kennedy et al. Expert Opinion On Drug Safety
- PTEN and the PI3-Kinase Pathway in Cancer
- (2008) Nader Chalhoub et al. Annual Review of Pathology-Mechanisms of Disease
- A Transcription-Independent Function of FOXO1 in Inhibition of Androgen-Independent Activation of the Androgen Receptor in Prostate Cancer Cells
- (2008) P. Liu et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started